T3 Pharmaceuticals Company
The vision of T3 Pharmaceuticals is to improve the lives of cancer patients with highly innovative treatments. Despite significant advances of classical therapies, there remains a high need for novel and innovative medicines to treat cancer. T3 Pharmaceuticals is dedicated to fill this gap by developing highly specific and efficient treatments using live bacteria.
Investors
.jpg)
Connections
Headquarters:
Basel, Basel-Stadt, Switzerland, Europe
Founded Date:
2015-01-01
Industry:
Cell, Gene & Biologics Therapeutics
Employee Number:
1-10
Super Industry:
Biopharma & Life Science Tools
Phone Number:
+410612672074
Investors:
Boehringer Ingelheim Venture Fund, Innosuisse, Reference Capital SA, Swiss Federal Commission for Innovation and Technology, Wille Finance
Ipo Status:
private
City:
Basel
Region:
Basel-Stadt
Country:
Switzerland
Founders:
Christoph Kasper, Simon J. Ittig